Since TDP-43 aggregates are found in the vast majority of patients, ensuring an adequate mitophagy activity in order to maintain a healthy pool of mitochondria is a promising opportunity for ALS treatment. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.